Document:

<PAGE>
                                                                   EXHIBIT 10.34

                            INCENTIVE STOCK OPTION

                                Non-transferable

                                  G R A N T TO

                         -----------------------------
                                (the "Optionee")

     the right to purchase from CTI Molecular Imaging, Inc. (the "Company")

                                  -----------

 shares of its common stock, $0.01 par value, at the price of $_____ per share

pursuant to and subject to the provisions of the CTI Molecular Imaging, Inc.
2002 Stock Option Plan (the "Plan") and to the terms and conditions set forth
on the following page.

[USE THE FOLLOWING SENTENCE HERE IF THE OPTIONEE HAS BEEN EMPLOYED 10 OR MORE
YEARS AS OF THE DATE OF GRANT:]

The Options are fully vested and exercisable as to all of the Option Shares as
of the Grant Date.

[OTHERWISE USE THE FOLLOWING LEAD-IN AND INSERT THE APPROPRIATE TABLE BELOW:]

Unless vesting is accelerated in accordance with the Plan or in the discretion
of the Committee, the Options shall vest (become exercisable) in accordance
with the following schedule:

[INSERT THIS TABLE IF OPTIONEE HAS BEEN EMPLOYED BETWEEN 5 AND 10 YEARS AS OF
THE GRANT DATE AND DELETE THE OTHER TABLE.]

<TABLE>
<CAPTION>
                       Date                          Cumulative Number of
                                                     Option Shares Vested
                       ----                          --------------------
          <S>                                        <C>
                    Grant Date                                __%
          1st Anniversary of Grant Date                       __%
          2nd Anniversary of Grant Date                       __%
</TABLE>

[INSERT THIS TABLE IF OPTIONEE HAS BEEN EMPLOYED LESS THAN 5 YEARS AS OF THE
GRANT DATE AND DELETE THE OTHER TABLE.]

<TABLE>
<CAPTION>
                       Date                          Cumulative Number of
                                                     Option Shares Vested
                       ----                          --------------------
          <S>                                        <C>
                    Grant Date                                __%
          1st Anniversary of Grant Date                       __%
          2nd Anniversary of Grant Date                       __%
          3rd Anniversary of Grant Date                       __%
</TABLE>

IN WITNESS WHEREOF, CTI Molecular Imaging, Inc., acting by and through its duly
authorized officers, has caused this Agreement to be executed as of the Grant
Date.

                                    CTI MOLECULAR IMAGING, INC.

                                    By:
                                        ---------------------------------------
                                    Its:  Authorized Officer

                                    Grant Date:
                                                 ------------------------------

                                    Accepted by Optionee:
                                                          ---------------------

<PAGE>

TERMS AND CONDITIONS

         1.       Grant of Option. CTI Molecular Imaging, Inc. (the "Company")
hereby grants to the Optionee named on Page 1 hereof ("Optionee"), under the
CTI Molecular Imaging, Inc. 2002 Long-Term Incentive Plan (the "Plan"), stock
options to purchase from the Company (the "Options"), on the terms and on
conditions set forth in this agreement (this "Agreement"), the number of shares
indicated on Page 1 of the Company's $0.01 par value common stock, at the
exercise price per share set forth on Page 1. Capitalized terms used herein and
not otherwise defined shall have the meanings assigned to such terms in the
Plan.

         2.       Vesting of Options. The Option shall vest (become exercisable)
in accordance with the schedule shown on Page 1 of this Agreement.
Notwithstanding the foregoing vesting schedule, upon Optionee's death or
Disability during his or her Continuous Status as a Participant, or if
Optionee's employment is terminated by the Company without Cause or by Optionee
for Good Reason within two years after the effective date of a Change of
Control, all Options shall become fully vested and exercisable.

         For purposes of computing the number of Option Shares that Optionee
has a right to acquire by exercise of these Options, fractional Shares shall be
disregarded and the next higher whole number of Shares shall be used, rounding
all fractions upward.

         3.       Period of Options and Limitations on Right to Exercise. The
Options will, to the extent not previously exercised, lapse upon the earliest
to occur of the following circumstances:

         (a) 5:00 p.m., Eastern Time, on the tenth anniversary of the Grant
Date (the "Expiration Date").

         (b) Three months after the termination of Optionee's Continuous Status
as a Participant for any reason other than (i) for Cause or (ii) by reason of
Optionee's death or Disability.

         (c) Twelve months after the date of the termination of Optionee's
Continuous Status as a Participant by reason of Disability.

         (d) Twelve months after the date of Optionee's death, if Optionee dies
while employed, or during the three-month period described in subsection (b)
above or during the twelve-month period described in subsection (c) above and
before the Options otherwise lapse. Upon Optionee's death, the Options may be
exercised by Optionee's beneficiary designated pursuant to the Plan.

         (e) Thirty days after the date of the termination of Optionee's
Continuous Status as a Participant if such termination is for Cause.

         The Board may, prior to the lapse of the Options under the
circumstances described in paragraphs (b), (c), (d) or (e) above, extend the
time to exercise the Options as determined by the Board in writing, but if the
Options are so extended and are exercised after the dates specified in
subsections (b) or (c) above, the Options will automatically become
Non-Qualified Stock Options. If Optionee returns to employment with the Company
during the designated post-termination exercise period, then Optionee shall be
restored to the status Optionee held prior to such termination but no vesting
credit will be earned for any period Optionee was not in Continuous Status as a
Participant. If Optionee or his or her beneficiary exercises an Option after
termination of service, the Options may be exercised only with respect to the
Shares that were otherwise vested on Optionee's termination of service.

         4.       Exercise of Option. The Options shall be exercised by (a)
written notice directed to the Secretary of the Company or his or her designee
at the address and in the form specified by the Secretary from time to time and
(b) payment to the Company in full for the Shares subject to such exercise
(unless the exercise is a broker-assisted cashless exercise, as described
below). If the person exercising an Option is not Optionee, such person shall
also deliver with the notice of exercise appropriate proof of his or her right
to exercise the Option. Payment for such Shares shall be in (a) cash, (b)
Shares previously acquired by the purchaser, which have been held by the
purchaser for at least six months, or (c) any combination thereof, for the
number of Shares specified in such written notice. The fair market value of
surrendered Shares for this purpose shall be the Fair Market Value, calculated
as provided in the Plan, as of the last trading day immediately prior to the
exercise date. To the extent permitted under Regulation T of the Federal
Reserve Board, and subject to applicable securities laws and the Company's
adoption of such program in connection with the Plan, the Options may be
exercised through a broker in a so-called "cashless exercise" whereby legal
title to the Option Shares passes to Optionee upon the exercise date, and the
broker sells the Option Shares on behalf of Optionee and delivers cash sales
proceeds to the Company in payment of the exercise price. In such case, the
date of exercise shall be deemed to be the date on which notice of exercise is
received by the Company and the exercise price shall be delivered to the
Company on the settlement date.

         5.       Beneficiary Designation. Optionee may, in the manner
determined by the Committee, designate a beneficiary to exercise the rights of
Optionee hereunder and to receive any distribution with respect to the Options
upon Optionee's death. A beneficiary, legal guardian, legal representative, or
other person claiming any rights hereunder is subject to all terms and
conditions of this Agreement and the Plan, and to any additional restrictions
deemed necessary or appropriate by the Committee. If no beneficiary has been
designated or survives Optionee, the Options may be exercised by the legal
representative of Optionee's estate, and payment shall be made to Optionee's
estate. Subject to the foregoing, a beneficiary designation may be changed or
revoked by Optionee at any time provided the change or revocation is filed with
the Company.

         6.       Limitation of Rights. The Options do not confer to Optionee
or Optionee's beneficiary designated pursuant to Paragraph 5 any rights of a
shareholder of the Company unless and until Shares are in fact issued to such
person in connection with the exercise of the Options. Nothing in this
Agreement shall interfere with or limit in any way the right of the Company or
any Affiliate to terminate Optionee's service at any time, nor confer upon
Optionee any right to continue in the service of the Company or any Affiliate.

         7.       Stock Reserve. The Company shall at all times during the term
of this Agreement reserve and keep available such number of Shares as will be
sufficient to satisfy the requirements of this Agreement.

         8.       Restrictions on Transfer and Pledge. No right or interest of
Optionee in the Options may be pledged, encumbered, or hypothecated to or in
favor of any party other than the Company or an Affiliate, or shall be subject
to any lien, obligation, or liability of Optionee to any other party other than
the Company or an Affiliate. The Options are not assignable or transferable by
Optionee other than by will or the laws of descent and distribution. The
Options may be exercised during the lifetime of Optionee only by Optionee.

         9.       Restrictions on Issuance of Shares. If at any time the
Committee shall determine in its discretion, that registration, listing or
qualification of the Shares covered by the Options upon any Exchange or under
any foreign, federal, or local law or practice, or the consent or approval of
any governmental regulatory body, is necessary or desirable as a condition to
the exercise of the Options, the Options may not be exercised in whole or in
part unless and until such registration, listing, qualification, consent or
approval shall have been effected or obtained free of any conditions not
acceptable to the Committee.

         10.      Notification of Disposition. Optionee agrees to notify the
Company in writing within 30 days of any disposition of Shares acquired by
Optionee pursuant to the exercise of Options, if such disposition occurs within
two years of the Grant Date, or one year of the date of exercise, of the
Options. The Company has the authority and the right to deduct or withhold, or
require Optionee to remit to the Company, an amount sufficient to satisfy
federal, state, and local taxes required by law to be withheld with respect to
any disposition of Shares prior to the expiration of two years of the Grant
Date, or one year of the date of exercise, of the Options.

         11.      Interpretation. It is the intent of the parties hereto that
the Options qualify for incentive stock option treatment pursuant to, and to
the extent permitted by, Section 422 of the Code. All provisions hereof are
intended to have, and shall be construed to have, such meanings as are set
forth in applicable provisions of the Code and Treasury Regulations to allow
the Options to so qualify. To the extent that such any portion of the Options
fail to qualify for incentive stock option treatment pursuant to Section 422 of
the Code, such nonqualifying portion of the Options shall be Non-Qualified
Stock Options, governed under Section 83 of the Code.

         12.      Plan Controls. The terms contained in the Plan are
incorporated into and made a part of this Agreement and this Agreement shall be
governed by and construed in accordance with the Plan. In the event of any
actual or alleged conflict between the provisions of the Plan and the
provisions of this Agreement, the provisions of the Plan shall be controlling
and determinative.

         13.      Successors. This Agreement shall be binding upon any
successor of the Company, in accordance with the terms of this Agreement and
the Plan.

         14.      Severability. If any one or more of the provisions contained
in this Agreement is invalid, illegal or unenforceable, the other provisions of
this Agreement will be construed and enforced as if the invalid, illegal or
unenforceable provision had never been included.

         15.      Notice. Notices and communications under this Agreement must
be in writing and either personally delivered or sent by registered or
certified United States mail, return receipt requested, postage prepaid.
Notices to the Company must be addressed to:

                  CTI Molecular Imaging, Inc.
                  810 Innovation Drive
                  Knoxville, Tennessee  37932
                  Attn: Secretary

or any other address designated by the Company in a written notice to Optionee.
Notices to Optionee will be directed to the address of Optionee then currently
on file with the Company, or at any other address given by Optionee in a
written notice to the Company.<PAGE>
                                                                   EXHIBIT 10.35

                           RESTRICTED STOCK AGREEMENT

                                Non-transferable

                                    GRANT TO

                         ------------------------------
                                  ("Grantee")

               by CTI Molecular Imaging, Inc. (the "Company") of

                            ------------------------

           shares of its common stock, $0.01 par value (the "Shares")

pursuant to and subject to the provisions of the CTI Molecular Imaging, Inc.
2002 Long-Term Incentive Plan (the "Plan") and to the terms and conditions set
forth on the following page (the "Terms and Conditions").

         Unless sooner vested in accordance with Section 3 of the Terms and
Conditions, the restrictions imposed under Section 2 of the Terms and
Conditions will expire as to the following percentage of the Shares awarded
hereunder, on the following respective dates:

<TABLE>
<CAPTION>
                                                              Date of Expiration
             Percentage of Shares                               of Restrictions
             --------------------                        -----------------------------
             <S>                                         <C>
                     ___%                                1st Anniversary of Grant Date
                     ___%                                2nd Anniversary of Grant Date
                     ___%                                3rd Anniversary of Grant Date
                     ___%                                4th Anniversary of Grant Date
</TABLE>

         IN WITNESS WHEREOF, CTI Molecular Imaging, Inc., acting by and through
its duly authorized officers, has caused this Agreement to be executed as of
the Grant Date.

                                     CTI Molecular Imaging, Inc.

                                     By:
                                        ---------------------------------------
                                           Its:  Authorized Officer

                                     Grant Date:
                                                 ------------------------------

                                     Accepted by Grantee:
                                                          ---------------------

<PAGE>

TERMS AND CONDITIONS

1.       Grant of Shares. CTI Molecular Imaging, Inc. (the "Company")
hereby grants to the Grantee named on Page 1 hereof ("Grantee"), subject to the
restrictions and the other terms and conditions set forth in the CTI Molecular
Imaging, Inc. 2002 Long Term Incentive Plan (the "Plan") and in this award
agreement (this "Agreement"), the number of shares indicated on Page 1 hereof
of the Company's $0.01 par value common stock (the "Shares"). Capitalized terms
used herein and not otherwise defined shall have the meanings assigned to such
terms in the Plan.

2.       Restrictions. The Shares are subject to each of the following
restrictions. "Restricted Shares" mean those Shares that are subject to the
restrictions imposed hereunder which restrictions have not then expired or
terminated. Restricted Shares may not be sold, transferred, exchanged,
assigned, pledged, hypothecated or otherwise encumbered. If Grantee's
employment with the Company or any Affiliate terminates for any reason other
than as set forth in paragraph (b) or (c) of Section 3 hereof (including,
without limitation, Grantee's Retirement), then Grantee shall forfeit all of
Grantee's right, title and interest in and to the Restricted Shares as of the
date of employment termination, such Restricted Shares shall revert to the
Company immediately following the event of forfeiture. The restrictions imposed
under this Section shall apply to all shares of the Company's common stock or
other securities issued with respect to Restricted Shares hereunder in
connection with any merger, reorganization, consolidation, recapitalization,
stock dividend or other change in corporate structure affecting the common
stock of the Company.

3.       Expiration and Termination of Restrictions. The restrictions imposed
under Section 2 will expire on the earliest to occur of the following (the
period prior to such expiration being referred to herein as the "Restricted
Period"):

      (a) As to the percentages of the Shares on the dates specified on page
1 hereof; or

      (b) The date of termination of Grantee's employment by reason of death
or Disability; or

      (c) The date of termination of Grantee's employment by the Company
without Cause, or Grantee's resignation for Good Reason, within 24 months after
the occurrence of a Change of Control.

4.       Delivery of Shares. The Shares will be registered in the name of
Grantee as of the Grant Date of Grant and will be held by the Grantee during
the Restricted Period in certificated or uncertificated form. If a certificate
for Restricted Shares is issued during the Restricted Period with respect to
such Shares, such certificate shall be registered in the name of Grantee and
shall bear a legend in substantially the following form (in addition to any
legend required under applicable state securities laws):

"This certificate and the shares of stock represented hereby are subject to the
terms and conditions (including forfeiture and restrictions against transfer)
contained in a Restricted Stock Agreement between the registered owner of the
shares represented hereby and CTI Molecular Imaging, Inc. Release from such
terms and conditions shall be made only in accordance with the provisions of
such Agreement, copies of which are on file in the offices of CTI Molecular
Imaging, Inc."

Stock certificates for the Shares, without the first above legend, shall be
delivered to Grantee or Grantee's designee upon request of Grantee after the
expiration of the Restricted Period, but delivery may be postponed for such
period as may be required for the Company with reasonable diligence to comply
if deemed advisable by the Company, with registration requirements under the
1933 Act, listing requirements under the rules of any stock exchange, and
requirements under any other law or regulation applicable to the issuance or
transfer of the Shares.

5.       Voting and Dividend Rights. Grantee, as beneficial owner of the
Shares, shall have full voting and dividend rights with respect to the Shares
during and after the Restricted Period. If Grantee forfeits any rights he may
have under this Agreement in accordance with Section 3, Grantee shall no longer
have any rights as a stockholder with respect to the Restricted Shares or any
interest therein and Grantee shall no longer be entitled to receive dividends
on such stock. In the event that for any reason Grantee shall have received
dividends upon such stock after such forfeiture, Grantee shall repay to the
Company any amount equal to such dividends.

6.       Changes in Capital Structure. The provisions of the Plan shall apply
in the case of a change in the capital structure of the Company. Without
limiting the foregoing, in the event of a subdivision of the outstanding Stock
(stock-split), a declaration of a dividend payable in Stock, or a combination
or consolidation of the outstanding Stock into a lesser number of shares, the
Shares then subject to this Agreement shall automatically be adjusted
proportionately.

7.       No Right of Continued Employment. Nothing in this Agreement shall
interfere with or limit in any way the right of the Company or any Affiliate to
terminate Grantee's employment at any time, nor confer upon Grantee any right to
continue in the employ of the Company or any Affiliate.

8.     Payment of Taxes.

         (a)      Upon issuance of the Shares hereunder, Grantee may make an
election to be taxed upon such award under Section 83(b) of the Code. To effect
such election, Grantee may file an appropriate election with Internal Revenue
Service within thirty (30) days after award of the Shares and otherwise in
accordance with applicable Treasury Regulations.

         (b)      Grantee will, no later than the date as of which any amount
related to the Shares first becomes includable in Grantee's gross income for
federal income tax purposes, pay to the Company, or make other arrangements
satisfactory to the Committee regarding payment of, any federal, state and
local taxes of any kind (including Grantee's FICA obligation) required by law
to be withheld with respect to such amount. The obligations of the Company
under this Agreement will be conditional on such payment or arrangements, and
the Company, and, where applicable, its Affiliates will, to the extent
permitted by law, have the right to deduct any such taxes from any payment of
any kind otherwise due to Grantee.

9.       Amendment. The Committee may amend, modify or terminate this Agreement
without approval of Grantee; provided, however, that such amendment,
modification or termination shall not, without Grantee's consent, reduce or
diminish the value of this award determined as if it had been fully vested
(i.e., as if all restrictions on the Shares hereunder had expired) on the date
of such amendment or termination.

10.      Plan Controls. The terms contained in the Plan are incorporated into
and made a part of this Agreement and this Agreement shall be governed by and
construed in accordance with the Plan. In the event of any actual or alleged
conflict between the provisions of the Plan and the provisions of this
Agreement, the provisions of the Plan shall be controlling and determinative.

11.      Successors. This Agreement shall be binding upon any successor of the
Company, in accordance with the terms of this Agreement and the Plan.

12.      Severability. If any one or more of the provisions contained in this
Agreement are invalid, illegal or unenforceable, the other provisions of this
Agreement will be construed and enforced as if the invalid, illegal or
unenforceable provision had never been included.

13.      Notice. Notices and communications under this Agreement must be in
writing and either personally delivered or sent by registered or certified
United States mail, return receipt requested, postage prepaid. Notices to the
Company must be addressed to:

         CTI Molecular Imaging, Inc.
         810 Innovation Drive
         Knoxville, Tennessee  37932
         Attn: President

or any other address designated by the Company in a written notice to Grantee.
Notices to Grantee will be directed to the address of Grantee then currently on
file with the Company, or at any other address given by Grantee in a written
notice to the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]